Stories from The University of Texas Health Science Center at Houston (UTHealth Houston)
December 6, 2022
A new risk score could help clinicians differentiate viral meningitis from community-acquired bacterial meningitis (CABM), according to a review article by Rodrigo Hasbun, MD, MPH, at UTHealth Houston.
December 2, 2022
A translational research study from collaborating UTHealth Houston laboratories of Mikhail Kolonin, PhD, and Absalon Gutierrez, MD, on the new mechanism mediating the anti-diabetic effects of incretins has been published in Cell Reports Medicine.
December 1, 2022
A five-year, nearly $3.5 million grant to study the mechanisms of brain receptors involved in neurological disorders such as learning disabilities has been awarded to Vasanthi Jayaraman, PhD, of UTHealth Houston by the National Institutes of Health.
November 30, 2022
Mechanisms involved in the rapid, severe progression of fibrosis in the lung tissues of COVID-19 patients, a potentially fatal complication of the virus that damages and scars the lungs, have been uncovered by researchers led by UTHealth Houston.
November 21, 2022
What was supposed to be an ordinary cruise took a turn for the worse when “Hurricane Elda” unexpectedly made impact with the SS Gregory, wreaking havoc and sending it ashore. Bodies were flung from the ship while injured victims howled and awaited help.
November 18, 2022
A new method for determining whether patients with heart disease need coronary stents or bypass surgery is more effective than the angiogram, which is currently used, according to research from UTHealth Houston Heart & Vascular.
November 17, 2022
Paola Salazar was just 22 weeks along in her third pregnancy when strong labor pains sent her to the hospital where UTHealth Houston physicians worked hard to give little Jeremiah one more week in his mother’s womb.
November 14, 2022
Three faculty members who have demonstrated longstanding excellence in areas of teaching, research, and clinical care, and another recognized for overall exemplary dedication and service, received top honors from UTHealth Houston President Giuseppe N. Colasurdo, MD, Alkek-Williams Distinguished Chair, during a ceremony on Wednesday, Nov. 9.
November 10, 2022
A five-year, $3.3 million grant to research receptor-targeted fluorescence-guided surgery in pancreatic neuroendocrine tumors has been awarded to UTHealth Houston researcher Ali Azhdarinia, PhD, by the National Institutes of Health.
November 10, 2022
Research from McGovern Medical School’s Department of Pediatrics at UTHealth Houston has yielded a noninvasive diagnostic tool for an increasingly prevalent chronic immune system disease, eosinophilic esophagitis (EoE).
Use the form below to perform a new search.